Revenue

9 Months Ended

Mar. 31, 2023

Revenue From Contract With Customer [Abstract]

Revenue

Note 5. – Revenue

Revenues by payor were as follows for the three and nine months ended March 31, 2023 and 2022 were as shown below:

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2023		2022		2023		2022
Medicare	$	4,571	$	4,288	$	14,318	$	14,635
Medicaid		2,636		2,745		8,675		7,812
Retail and Institutional Pharmacy		1,633		1,504		5,667		4,467
Managed Care & Other Insurance		2,614		1,257		7,871		3,651
Self-pay		45		718		336		821
Other		34		15		95		77
Total Net Revenues	$	11,533	$	10,527	$	36,962	$	31,463

Revenues recognized from settlements of prior year Medicare and Medicaid cost reports of $151 and $186 were recorded in the three and nine months ended March 31, 2023 and 2022, respectively. Pharmacy segment net revenues increased for the nine months ended March 31, 2023 as a result of a reduction in the accrued sales tax liability of $2,615 as described in Note 10.